Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-19-031781
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-21 17:02:19
Reporting Period:
2019-05-17
Accepted Time:
2019-05-21 17:02:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347178 Vanda Pharmaceuticals Inc. VNDA Pharmaceutical Preparations (2834) 030491827
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1355537 Hristos Mihael Polymeropoulos 2200 Pennsylvania Avenue
Suite 300E
Washington DC 20037
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-17 97,373 $12.55 1,276,343 No 4 M Direct
Common Stock Disposition 2019-05-17 77,225 $15.56 1,199,118 No 4 S Direct
Common Stock Acquisiton 2019-05-20 73,608 $12.55 1,272,726 No 4 M Direct
Common Stock Disposition 2019-05-20 67,418 $15.12 1,205,308 No 4 S Direct
Common Stock Acquisiton 2019-05-21 79,019 $12.55 1,284,327 No 4 M Direct
Common Stock Disposition 2019-05-21 72,872 $15.34 1,211,455 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-05-17 97,373 $0.00 97,373 $12.55
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-05-20 73,608 $0.00 73,608 $12.55
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-05-21 79,019 $0.00 79,019 $12.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
152,627 2019-05-21 No 4 M Direct
79,019 2019-05-21 No 4 M Direct
0 2019-05-21 No 4 M Direct
Footnotes
  1. Represents shares of the Issuer's common stock sold to satisfy a portion of the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire May 21, 2019 as reflected in this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.38 to $16.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire May 21, 2019 as reflected in this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.99 to $15.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.92 to $15.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.
  6. The option vests each month with respect to 2.0833% of the aggregate option share total.